Catalyst Pharmaceuticals, Inc.
Florida
United States
375 articles about Catalyst Pharmaceuticals, Inc.
-
Catalyst Pharmaceutical Partners, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of CPP-115 Efficacy in Suppressing Infantile Spasms In Epilepsia
11/18/2013
-
Catalyst Pharmaceutical Partners, Inc. Announces Third Quarter 2013 Financial Results
11/14/2013
-
Catalyst Pharmaceutical Partners, Inc. Misled Investors According To A Newly Filed Class Action
11/13/2013
-
Catalyst Pharmaceutical Partners, Inc. Fights Greed Charges Over an Orphan Drug
11/7/2013
-
Catalyst Pharmaceutical Partners, Inc. Updates on Its Development Activities for Firdapse™
10/29/2013
-
Catalyst Pharmaceutical Partners, Inc. Announces Recommendation of Data Monitoring Committee to Continue Pivotal Phase 3 Clinical Trial for Firdapse
10/15/2013
-
Catalyst Pharmaceutical Partners, Inc. to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/4/2013
-
Catalyst Pharmaceutical Partners, Inc. to Present at Aegis Capital 2013 Healthcare Conference
9/25/2013
-
Catalyst Pharmaceutical Partners, Inc. Closes Previously Announced $15.1 Million Registered Direct Offering
9/10/2013
-
Catalyst Pharmaceutical Partners, Inc. Prices Registered Direct Public Offering
9/5/2013
-
Catalyst Pharmaceutical Partners, Inc. to Present at Rodman & Renshaw's 15th Annual Global Investment Conference
9/3/2013
-
Catalyst Pharmaceutical Partners, Inc. Gets Breakthrough Therapy Designation From FDA for Firdapse for the Treatment of LEMS; Stock Rockets +41.55% at Market Close (August 27, 2013)
8/28/2013
-
Catalyst Pharmaceutical Partners, Inc. Announces Second Quarter 2013 Financial Results
8/15/2013
-
Catalyst Pharmaceutical Partners, Inc. Regains Compliance With NASDAQ Minimum Bid Price Rule
8/2/2013
-
Catalyst Pharmaceutical Partners, Inc. Provides Update on FIRDAPSE Progress
6/27/2013
-
Catalyst Pharmaceutical Partners, Inc. Receives Extension to Regain Compliance With NASDAQ Listing Requirements
6/25/2013
-
Catalyst Pharmaceutical Partners, Inc. Reports First Quarter 2013 Financial Results
5/16/2013
-
Catalyst Pharmaceutical Partners, Inc. Reports Fourth Quarter and Year-End 2012 Financial Results
4/2/2013
-
Catalyst Pharmaceutical Partners, Inc. Announces Recommendation of Data Monitoring Committee for Pivotal Phase lll Clinical Trial for Firdapse(TM)
3/27/2013
-
Catalyst Pharmaceutical Partners, Inc. to Present at 25th Annual ROTH Conference
3/7/2013